Abstract:Objective To analyze the efficacy and safety of progesterone sustained-released vaginal gel for luteal phase support in vitro fertilization-embryo transfer(IVF-ET).Methods From January to December 2015,992 patients who were agreed on long-term regimen of IVF-ET were selected.According to different progesterone-support regimens,they were divided into group A(muscular injection progesterone 60 mg,n=56),group B(muscular injection progesterone 40 mg,n=740), and group C(external application of progesterone sustained-released vaginal gel,n=196).The pregnancy rate,implantation rate,multiple-gestation pregnancy rate,miscarriage rate,ectopic pregnancy rate and incidence of adverse drug reactions were compared among the three groups.Results There was no significant difference in pregnancy rate,implantation rate, multiple gestation pregnancy rate,miscarriage rate,orectopic pregnancy rate among the three groups(P>0.05).However,the pregnancy rate,multiple gestation pregnancy rate and implantation rate had increasing tendency,and miscarriage rate was in a decrease tendency in group C.The total incidence of adverse drug reactions was significantly lower than that in the group A and B,the difference was statistically significant(P<0.01).Conclusion Progesterone sustained-released vaginal gel is one of the effective and safe methods for luteal phase support in IVF-ET.
王美仙; 张扬 ;邵小光. 黄体酮阴道缓释凝胶在体外受精-胚胎移植黄体支持中的应用效果[J]. 中国当代医药, 2017, 24(3): 71-73.
WANG Mei-xian;ZHANG Yang;SHAO Xiao-guang. Application effect of progesterone sustained-released vaginal gel for luteal phase support in vitro fertilization and embryo transfer. 中国当代医药, 2017, 24(3): 71-73.
Fatemi HM,Popovic-Todorovic B,Papanikolau E,et al.An update of luteal phase support in stimulated IVF cycles[J]. Hum Reprod Update,2007,13(6):581-590.
[2]
Polyzos NP,Messini CI,Papanikolaou EG,et al.Vaginal pro gesterone gel for luteal phase support in IVF/ICSI cycles:a meta-analysis[J].Fertil Steril,2010,94(6):∶2083-2087.
[3]
孙赟,刘平,叶虹,等.黄体支持与孕激素补充共识[J].生殖与避孕,2015,35(1):1-8.
[4]
Vaisbuch E,de Ziegler D,Leong M,et al.Luteal-phase support in assisted reproduction treatment:real-life practices reported world wide by an updated website-based survey[J]. Reprod Biomed Online,2013,28(3):330-335.
Silverberg KM,Vaughn TC,Hansard L,et al.Vaginal(Crinone 8%)vs.intramuscular progesterone in oil for luteal phase support in invitro fertilization:a large prospective trial[J].Fertil Steril,2012,97(2):344-348.
[14]
Raghupathy R,Al-Mutawa E,Al-Azemi M,et al.Progesterone-induced blocking factor(PIBF)modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery[J].J Reprod Immunol,2009,80(1-2):91-99.
[15]
Nardo LG.Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproductive cycles[J].Reprod Biomed Online,2006,13(1):47-57.